Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 22c

Zimmer Biomet Holdings (NYSE: ZBH) reported Q1 EPS of $2.09, $0.22 better than the analyst estimate of $1.87. Revenue for the quarter came in at $2.09 billion versus the consensus estimate of $2.06 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2026 EPS of $8.40-$8.55, versus the consensus of $8.40.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• JPMorgan Starts Central Depository Services India Ltd (CDSL:IN) at Underweight
• South Korea's KOSPI Plunges 8%, Triggering Circuit Breaker